Ra Medical Stock Price Rallied 21% Premarket Amid Analyst Coverage

RA Medical Systems Inc (NYSEAMERICAN: RMED) stock price rallied 21% premarket despite not releasing any critical news before the open.

However, the rally could have been triggered by HC Wainwright & Co. initial coverage of the stock, where its analysts issued a buy rating on the stock with a price target of $12.

Ra Medical is considered a low stock float given that the number of its outstanding shares is 6.7 million, which could make it the target of a short squeeze given that it once traded above $9.

X testing X

WELCOME BONUS - Free Share Bundle When You Invest £50! Get up to £500 cashback for investing with IG.

Invest in 15,000+ shares and ETFs. Open an account now, invest at least £50, and you’ll get a free share bundle worth between £40 and £200. T&Cs apply.

5.0

Open Account Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.

The last significant announcement from Ra Medical was in August when it reported its second-quarter results where it generated net revenues of $1.0 million made up of $0.7 million in service and other revenues, while $0.3 million was from product sales.

The medical device company reported a net loss of $5.2 million in Q2 2021 compared to a $10.2 million net loss in Q2 2020. In addition, the firm was able to reduce its selling, general and administrative expenses during Q2.

Ra medical also reported its six-month results where it made net sales worth $2.1 million, a slight drop to the $2.3 million in net sales generated in Q2 2020.

However, the firm reduced its selling, general and administrative costs to $7.9 million compared to last year’s $14.2 million, which improved performance.

Today’s rally can be attributed to investors flocking to Ra Medical after analysts started covering its stocks with a positive outlook and a buy rating.

Meanwhile, Ra Medical shares should break above the next resistance level at $3.65 to rise to new highs. However, investors could also look to short the stock if it bounces off the resistance level and heads lower.

*This is not investment advice.

RA Medical stock price.

Ra Medical Systems stock price rallied 21% premarket to trade at $3.63, rising from Wednesday’s closing price of $3.00.

Should You Invest in Ra Medical Systems Shares?

One of the most frequently asked questions we receive is, “what stocks are best to buy right now?” It’s a wide-ranging question, but one that we have answered… Our AskTraders stock analysts regularly review the market and compile a list of which companies you should be adding to your portfolio, including short and longer-term positions. Here are the best stocks to buy right now

See our best stocks to buy now guide